CCM
SGYP

Cadence Capital Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Cadence Capital Management’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-64,415
Closed -$365K – 681
2015
Q4 		$365K Buy
+64,415
New +$393K 0.02% 520

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cadence Capital Management's SGYP Position: Q1 2016 in Review

Cadence Capital Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2016, closing a stake of 64,415 shares — an estimated $365K sold.

Cadence Capital Management first reported a position in SGYP in Q4 2015 and held it in 1 quarter. The position peaked at $365K in Q4 2015. 128 funds tracked by Wall St. Rank hold SGYP as of Q1 2016.

  • Cadence Capital Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2016 after selling out during the quarter.
  • Cadence Capital Management sold 64,415 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2016, an estimated $365K.
  • Cadence Capital Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2015 and held it in 1 quarter.
  • Cadence Capital Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $365K in Q4 2015.
  • 128 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2016.

Based on Cadence Capital Management's 13F filing for Q1 2016, filed 2 May 2016.